David C. Morris

4.3k total citations · 1 hit paper
44 papers, 3.3k citations indexed

About

David C. Morris is a scholar working on Molecular Biology, Rheumatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David C. Morris has authored 44 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Rheumatology and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David C. Morris's work include Alkaline Phosphatase Research Studies (13 papers), Bone health and treatments (6 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). David C. Morris is often cited by papers focused on Alkaline Phosphatase Research Studies (13 papers), Bone health and treatments (6 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). David C. Morris collaborates with scholars based in United States, Finland and Japan. David C. Morris's co-authors include Steven A. Kliewer, Jürgen M. Lehmann, Timothy M. Willson, H. Clarke Anderson, Howard H.T. Hsu, Claudius E. Robinson, Xiying Wu, Jeffrey M. Gimble, Katherine A. Kelly and Nikolas H. Blevins and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

David C. Morris

44 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation

1995 1.8k citations Steven A. Kliewer, Timothy M. Willson et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David C. Morris United States	22	2.1k	725	545	410	410	44	3.3k
Micheline Duriez France	38	2.4k 1.1×	805 1.1×	280 0.5×	173 0.4×	510 1.2×	59	5.6k
Tom A. Gardiner United Kingdom	44	3.0k 1.4×	483 0.7×	135 0.2×	159 0.4×	475 1.2×	133	7.0k
Philip Babij United States	26	2.1k 1.0×	425 0.6×	176 0.3×	463 1.1×	326 0.8×	37	3.4k
Christina N. Bennett United States	15	3.6k 1.7×	895 1.2×	118 0.2×	645 1.6×	445 1.1×	17	5.0k
Tae‐Hwa Chun Japan	29	1.6k 0.7×	750 1.0×	140 0.3×	157 0.4×	731 1.8×	51	3.4k
Long Pang China	20	2.9k 1.3×	381 0.5×	201 0.4×	226 0.6×	469 1.1×	52	4.5k
Nahid Hemati United States	13	2.5k 1.2×	790 1.1×	78 0.1×	505 1.2×	324 0.8×	16	3.7k
Ana Sánchez Spain	32	1.4k 0.7×	352 0.5×	466 0.9×	144 0.4×	123 0.3×	90	4.1k
Attila Szántó Hungary	30	2.0k 0.9×	355 0.5×	125 0.2×	419 1.0×	509 1.2×	67	3.3k
Hyun Kook South Korea	41	3.7k 1.7×	372 0.5×	113 0.2×	444 1.1×	808 2.0×	119	5.4k

Countries citing papers authored by David C. Morris

Since Specialization

Citations

This map shows the geographic impact of David C. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Morris more than expected).

Fields of papers citing papers by David C. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Morris. The network helps show where David C. Morris may publish in the future.

Co-authorship network of co-authors of David C. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Morris. A scholar is included among the top collaborators of David C. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Morris. David C. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laitinen, Tuomo, et al.. (2022). Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platform. Scientific Reports. 12(1). 12820–12820. 6 indexed citations

Morris, David C., Sankar P. Chaki, Alvin T. Yeh, et al.. (2017). Nck deficiency is associated with delayed breast carcinoma progression and reduced metastasis. Molecular Biology of the Cell. 28(24). 3500–3516. 18 indexed citations

Morris, David C., Christopher Sewell, F. Barbagli, et al.. (2006). Visuohaptic simulation of bone surgery for training and evaluation. IEEE Computer Graphics and Applications. 26(6). 48–57. 149 indexed citations

Champion, Brian, Christopher L. Holley, Caroline J. Simmons, et al.. (1998). RoBo-1, a Novel Member of the Urokinase Plasminogen Activator Receptor/CD59/Ly-6/Snake Toxin Family Selectively Expressed in Rat Bone and Growth Plate Cartilage. Journal of Biological Chemistry. 273(7). 3878–3883. 33 indexed citations

Brown, Kathleen K., William O. Wilkison, H. Roger Brown, et al.. (1996). Activation of the Nuclear Receptor Peroxisome Proliferator-activated Receptor γ Promotes Brown Adipocyte Differentiation. Journal of Biological Chemistry. 271(47). 29909–29914. 141 indexed citations

Kliewer, Steven A., et al.. (1995). A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 83(5). 813–819. 1776 indexed citations breakdown →

Hsu, Howard H.T., et al.. (1993). In vitro Ca deposition by rat matrix vesicles: Is the membrane association of alkaline phosphatase essential for matrix vesicle-mediated calcium deposition?. International Journal of Biochemistry. 25(12). 1737–1742. 28 indexed citations

Anderson, H. Clarke, Daniel J. Stechschulte, Howard H.T. Hsu, & David C. Morris. (1992). Comparison of normal and rachitic rat matrix vesicles. Bone and Mineral. 17(2). 119–122. 2 indexed citations

Masuhara, K., Sadao Suzuki, Hideki Yoshikawa, et al.. (1992). Development of a monoclonal antibody specific for human bone alkaline phosphatase. Bone and Mineral. 17(2). 182–186. 9 indexed citations

10.

Remmler, Daniel, et al.. (1992). Osseous Expansion of the Cranial Vault by Craniotasis. Plastic & Reconstructive Surgery. 89(5). 787–797. 33 indexed citations

11.

Anderson, H. Clarke, Kazuomi Sugamoto, David C. Morris, Howard H.T. Hsu, & Thomas R. Hunt. (1992). Bone-inducing agent (BIA) from cultured human Saos-2 osteosarcoma cells. Bone and Mineral. 16(1). 49–62. 30 indexed citations

12.

Morris, David C., Kensaku Masuhara, Kunio Takaoka, Keiro Ono, & H. Clarke Anderson. (1992). Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone. Bone and Mineral. 19(3). 287–298. 65 indexed citations

13.

Morris, David C., et al.. (1992). Immunochemical and immunocytochemical identification of matrix vesicle proteins. Bone and Mineral. 17(2). 209–213. 12 indexed citations

14.

Masuhara, K., et al.. (1991). Monoclonal antibody against human bone alkaline phosphatase. International Orthopaedics. 15(1). 61–64. 8 indexed citations

15.

Morris, David C., et al.. (1990). Enzyme cytochemical localization of alkaline phosphatase in cultures of chondrocytes derived from normal and rachitic rats. Bone. 11(5). 345–352. 4 indexed citations

16.

Morris, David C., H. Clarke Anderson, Hideki Yoshikawa, et al.. (1990). Matrix vesicle calcification of ectopically induced osteoid tissue in 1-hydroxethylidene-1, 1-bisphosphonate (HEBP)-treated mice☆. Bone. 11(4). 281–286. 4 indexed citations

17.

Anderson, H. Clarke, et al.. (1989). Osteoporosis associated with mastocytosis confined to bone: Report of two cases. Bone. 10(4). 237–241. 30 indexed citations

18.

Morris, David C., et al.. (1989). Heterotopic ossification: A case report and immunohistochemical observations. Human Pathology. 20(1). 86–88. 37 indexed citations

19.

Morris, David C., et al.. (1988). Light microscopic localization of alkaline phosphatase in fetal bovine bone using immunoperoxidase and immunogold-silver staining procedures.. Journal of Histochemistry & Cytochemistry. 36(3). 323–327. 11 indexed citations

20.

Väänänen, Kalervo, et al.. (1987). Immunohistochemical study of alkaline phosphatase in growth plate cartilage, bone, and fetal calf isolated chondrocytes using monoclonal antibodies. Acta Histochemica. 82(2). 211–217. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact